In “Challenging Market Conditions,” ResMed Revenue Up 4%
ResMed’s revenue was $397.8 million for the quarter ended March 31, a 4% increase over the quarter ended March 31, 2013. Research and development expenses were $29.5 million for the quarter, or 7.4% of revenue. R&D...
Read More